ArticleBMC pulmonary medicine2025
Construction and validation of a risk prediction model for chronic obstructive pulmonary disease (COPD): a cross-sectional study based on the NHANES database from 2009 to 2018.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic value of ocular imaging biomarkers in chronic obstructive pulmonary disease: a multicenter prospective cross-sectional study.Journal of thoracic disease · 2026Article
- Development and Validation of a Predictive Nomogram for Progression from Pre-COPD to Spirometric COPD: A Multicenter Retrospective Cohort Study.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) is a major global public health concern, and early screening and identification of high-risk populations are critical for reducing the disease burden. Although several studies have explored the application of machine learning methods in COPD risk prediction, existing models often have limited feature dimensions and insufficient interpretability. Identifying key risk factors and constructing reliable predictive models remain challenges in clinical practice.
objectiveThis study aims to integrate multidimensional features based on data from the National Health and Nutrition Examination Survey (NHANES) and to compare the performance of different machine learning models in COPD risk prediction. The goal is to identify the optimal model and enhance its clinical applicability through interpretability analysis.
methodsThis study utilized data from the NHANES collected between 2009 and 2018. After systematic feature selection and preprocessing, three models were developed: multivariate binary logistic regression, XGBoost, and Multilayer Perceptron (MLP). Model training and evaluation were performed using stratified five-fold cross-validation. Model performance was comprehensively assessed based on accuracy, precision, recall, F1 score, and the area under the receiver operating characteristic curve (AUC). To enhance model transparency, the SHapley Additive Explanations (SHAP) method was employed to interpret key features and their influence trends within the MLP model.
resultsThe MLP model demonstrated the best performance across all evaluation metrics, achieving an average accuracy of 0.937, precision of 0.6624, recall of 0.6535, and F1 score of 0.657 in stratified five-fold cross-validation. The performance gap between the training and testing sets was minimal, indicating no obvious overfitting. SHAP analysis identified smoking years, asthma, age, dietary health status, total protein, red cell distribution width (RDW), BMI, marital status, secondhand smoke exposure, and total bilirubin as important predictive features. Furthermore, dependence plots revealed critical risk inflection points for key continuous variables.
conclusionBased on large-scale and multidimensional feature data, this study constructed a COPD risk prediction model with favorable performance and enhanced interpretability. The findings suggest that the MLP model has the potential to effectively identify individuals at high risk for COPD and may offer value in clinical applications. Future studies are warranted to integrate longitudinal follow-up data and multimodal information to further improve predictive accuracy and clinical interpretability, thereby providing a more robust foundation for early screening and personalized interventions in COPD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.